Trials / Completed
CompletedNCT00989040
Impact of Neuropathic Post-Zosterian Pain on the Cognition
Impact of Neuropathic Post-zosterian Pain on the Cognition (NPZ and Cognition)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
Pain is defined as a sensorial and emotional phenomenon and lead consequences on the cognition. These consequences could be increased with usual treatment. So the aim of this study is to explore these cognitive consequences.
Detailed description
Pilot prospective study with parallel groups
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | usual treatment: Versatis | * To explore if the cognition is failed in treated patients suffering of neuropathic postzosteria pain. * To see if treated patients with patch (Versatis®) have better cognition than treated patients without patch. |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-06-01
- Completion
- 2009-09-01
- First posted
- 2009-10-02
- Last updated
- 2012-01-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00989040. Inclusion in this directory is not an endorsement.